These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7184433)

  • 21. Clinical applications of the histoculture drug response assay.
    Furukawa T; Kubota T; Hoffman RM
    Clin Cancer Res; 1995 Mar; 1(3):305-11. PubMed ID: 9815986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Phase II study of 5'-DFUR in gastrointestinal and breast cancer].
    Tominaga T; Kitamura M; Hayashi K; Takahashi I; Kosaki G
    Gan To Kagaku Ryoho; 1985 Nov; 12(11):2172-8. PubMed ID: 2933000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized controlled trial of the efficacy of adjuvant immunochemotherapy and adjuvant chemotherapy for colorectal cancer, using different combinations of the intracutaneous streptococcal preparation OK-432 and the oral pyrimidines 1-hexylcarbamoyl-5-fluorouracil and uracil/tegafur.
    Watanabe M; Nishida O; Kunii Y; Kodaira S; Takahashi T; Tominaga T; Hojyo K; Kato T; Niimoto M; Kunitomo K; Isomoto H; Ohashi Y; Yasutomi M
    Int J Clin Oncol; 2004 Apr; 9(2):98-106. PubMed ID: 15108041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cooperative phase II study of spansule tegafur (SF-SP)].
    Taguchi T
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):319-26. PubMed ID: 6421250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A phase II trial of a new 5-fluorouracil derivative, BOF-A2 (Emitefur), for patients with advanced gastric cancer.
    Sugimachi K; Maehara Y
    Surg Today; 2000; 30(12):1067-72. PubMed ID: 11193737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A phase II study of 590-S (1-phthalidyl-5-fluorouracil) in patients with breast cancer--multi-center cooperative study--Cooperative Study Group of 590-S in Breast Cancer].
    Taguchi T; Terasawa T
    Gan To Kagaku Ryoho; 1987 Feb; 14(2):467-71. PubMed ID: 3813575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postoperative adjuvant use of carmofur for early breast cancer.
    Morimoto K; Koh M
    Osaka City Med J; 2003 Dec; 49(2):77-83. PubMed ID: 15179836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Serum concentration of HCFU and 5-FU after oral administration of HCFU in postoperative digestive cancer patients].
    Kuroda Y; Ohkuma R; Ohsato K
    Gan To Kagaku Ryoho; 1992 Sep; 19(11):1831-6. PubMed ID: 1519925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase II clinical evaluation of doxifluridine.
    Hurteloup P; Armand JP; Cappelaere P; Metz R; Kerbrat P; Keiling R; Fumoleau P; Fargeot P; Schraub S; Bastit P
    Cancer Treat Rep; 1986 Jun; 70(6):731-7. PubMed ID: 2942245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical evaluation of 1-hexylcarbamoyl-5-fluorouracil (HCFU) in hepatocellular carcinoma].
    Shiraishi K; Kubo Y; Majima Y; Sato K; Sakemi T; Sakai T; Hirai K; Ninomiya F; Abe M; Tanikawa K
    Gan To Kagaku Ryoho; 1984 Nov; 11(11):2348-55. PubMed ID: 6093712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prospective adjuvant chemotherapy, with mitomycin C plus long-term carmofur in colorectal cancer].
    Terabe K; Yamauchi M; Watanabe T; Ichihashi H; Takagi H; Imaizumi M; Kondo T
    Gan No Rinsho; 1986 Mar; 32(3):261-7. PubMed ID: 3086597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postoperative adjuvant chemotherapy with 1-hexylcarbamoyl-5-fluorouracil in patients with colorectal cancer and at a high risk for recurrence.
    Maehara Y; Sugimachi K; Ogawa M; Kakegawa T; Tomita M; Akiyoshi T
    Anticancer Res; 1998; 18(6B):4629-34. PubMed ID: 9891531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A phase II study of ranomustine (MCNU) tablets in patients with gastrointestinal cancer--by cooperative study group].
    Taguchi T
    Gan To Kagaku Ryoho; 1984 Nov; 11(11):2420-6. PubMed ID: 6497400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective adjuvant therapy with mitomycin C and carmofur (HCFU) for colorectal cancer, 10-year follow-up: Tokai HCFU Study Group, the first study for colorectal cancer.
    Ito K; Yamaguchi A; Miura K; Kato T; Koike A; Takagi H
    J Surg Oncol; 1996 May; 62(1):4-9. PubMed ID: 8618399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Distribution of 1-hexycarbamoyl-5-fluorouracil in rats and human patients, and clinical results in patients with colorectal cancer].
    Takashima S; Kinami Y; Kiriyama M; Tomita F; Ueno K; Miyazaki I
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):549-55. PubMed ID: 3954377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized controlled trial of 5-fluorouracil (5-FU) infusion combined with 1-hexylcarbamoyl-5-fluorouracil (HCFU) oral administration and HCFU alone as postoperative adjuvant chemotherapy for colorectal cancer.
    Iwagaki H; Tanaka N; Esato K; Kaibara N; Sano K; Dohi K; Nakamura T; Nakasato H; Orita K
    Anticancer Res; 2000; 20(5C):3727-34. PubMed ID: 11268446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A randomized controlled trial comparing short-term MF chemotherapy with MF and long-term carmofur chemotherapy as an adjuvant to curative resection of stomach cancer].
    Nakazato H; Koike A; Ichihashi H
    Gan No Rinsho; 1986 Feb; 32(2):159-64. PubMed ID: 3083146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Multicenter comparative study of the recurrence-inhibitory effect of oral fluoropyrimidine drugs in patients with colorectal cancer following curative resection].
    Sadahiro S; Mitomi T; Noto T; Kumada K; Hiki Y; Yamakawa T; Amano T; Oki S; Otani Y; Oka H; Takahashi T; Takemiya S; Nishiyama K; Yamamura T; Tsuchiya S; Ogawa N;
    Gan To Kagaku Ryoho; 2005 Jul; 32(7):997-1005. PubMed ID: 16044962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical study of HCFU and radiation therapy for head and neck cancer].
    Honda T
    Gan To Kagaku Ryoho; 1983 Mar; 10(3):799-804. PubMed ID: 6881999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A clinical study of radiotherapy with HCFU for advanced and recurrent breast cancers. Radiation and HCFU Study Group for breast cancer].
    Okawa T; Ikeda M; Mikuriya S; Hashimoto S; Amino S; Horiuchi J; Matsuda T; Ebata K; Kaneda K
    Gan No Rinsho; 1985 Feb; 31(2):131-6. PubMed ID: 2985837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.